Biotech Values

[iwfal]

If, on the other hand, the trial designers know about this psychological profile a priori, then the sensible thing to do is to exclude patients who have the profile.

So, should all trials be run with one strata? That is the logical outcome of your contention. And as you know more and more prognostics you need more and more trials - one for each strata.